Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic > DSM launches new lactase for lactose-free/reduced sugar dairy products

DSM launches new lactase for lactose-free/reduced sugar dairy products

ECHEMI 2020-12-01

DSM (DSM) announced the launch of its new Maxilact Super lactase, which is used to produce lactose-free, reduced-sugar dairy products to meet the growing consumer demand for lactose-free foods. The lactase can be used in milk, milk beverages, yogurt and various organic dairy products.



DSM claims that Maxilact Super can "break down lactose into a sweeter form", which can help products reduce sugar by up to 20%. At the same time, the enzyme can also reduce the hydrolysis time by 33%, helping to optimize production efficiency. Maxilact Super does not contain invertase and arylsulfatase. It has been reported that these two enzymes can produce off-flavors and reduce the stability of dairy products during the shelf life.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Company-Dynamic
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.